Please login to the form below
17
Revenue 2017Stelara
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Stelara was produced by Johnson & Johnson.
New data keeps AbbVie’s star pipeline therapies on track
The analysis concentrated on patient-reported outcomes data from two studies that compared risankizumab to J&J’s $4bn-a-year IL-12/IL-23 inhibitor Stelara (ustekinumab) and one against ... The analysis showed that 56% of patients on risankizumab were
BMS psoriasis drug hits the mark in phase II
including Johnson &Johnson’s Stelara (ustekinumab) and follow-up Tremfya (guselkumab), Sun Pharma’s Ilumya (tildrakizumab) and AbbVie’s recently-filed risankizumab.
AstraZeneca’s Lupus treatment misses mark in trial
Its blockbuster Stelara produced encouraging phase II results in the disease last November, while Gilead is working with Verily on an early stage research project to better understand the disease.
UK, Germany back routine use of J&J’s Tremfya
Tremfya (guselkumab) is a follow-up to J&J’s IL-23/IL-12 inhibitor Stelara (ustekinumab) that rakes in blockbuster revenues but is facing the threat of competition from newer ... Stelara was a $4bn product for J&J’s Janssen Pharma unit last year, but
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Account Manager
-
Negotiable
- Sudler London - Senior Medical Writer
-
Competitive
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Systematic Review Lead- London
-
Negotiable
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Sudler London - Account Director
-
Competitive
-
Event Manager – Medical Education
-
Salary TBC
-
Associate Scientific Director
-
Salary TBC
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
Subscribe to our email news alerts
- AZ prepares to file COPD triple, taking on rival GSK
- Controversy grows around GP at Hand service after minister’s endorsement
- AMICULUM® announces the opening of a new office in Manchester
- Teva wins FDA OK for crucial migraine drug
- AZ nabs US approval for new leukaemia drug Lumoxiti
- Gilead targets hep B in half a billion dollar deal with Precision BioSciences
PMHub
SpotMe
SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
